GA management involves identifying at-risk patients, assessing visual function, and referring for treatment when necessary.

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

The beginning of the new CPD cycle means it is time to prepare a new professional development plan (PDP) and sketch out areas ...

Rates of nearsightedness, or myopia, are skyrocketing in kids—and scientists say it has to do with how little time they’re ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

CES 2025 is just around the corner, and our favorite companies are showing off their latest and greatest tech early. One of those companies is Solidd.

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects millions but has no medical cure.

For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...

Headset designed for healthcare professionals to debut at Pepcom at CES on January 7 in Las Vegas. COLORADO SPRINGS, Colo.